Status:
COMPLETED
Pulsatile Perfusion Preservation in Kidney Transplantation From Expanded Criteria Donors
Lead Sponsor:
Hospices Civils de Lyon
Conditions:
Chronic Renal Failure
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
Our hypothesis is that the Waters Medical® pulsatile perfusion machine (RM 3) is a way to improve delayed graft function (DGF) in marginal grafts, and some perfusion profiles (flow, pressure, resistan...
Eligibility Criteria
Inclusion
- Inclusion Criteria for marginal graft:
- donors over 60 years of age
- donors between 50 and 60 years of age with at least one of the following characteristics :
- history of diabetes mellitus
- history of high blood pressure
- serum creatinine \>1,5 mg/dL
- death by stroke (haemorrhagic or thrombotic)
- Inclusion criteria for recipient :
- patients registered on the kidney transplant waiting list likely to receive a marginal kidney
- immunized patients whose anti-HLA antibody specificities have been determined
- Exclusion Criteria for recipient:
- pregnant or breastfeeding women
- people who have been incarcerated
- minors
- adults under guardianship
- people who are not affiliated with the French healthcare system
- people with HLA immunization whose HLA antibody specificities have not been determined
Exclusion
Key Trial Info
Start Date :
April 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2016
Estimated Enrollment :
162 Patients enrolled
Trial Details
Trial ID
NCT01170910
Start Date
April 1 2010
End Date
August 1 2016
Last Update
May 31 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Service d'Urologie et Chirurgie de la Tranplantation - Hôpital Edourad Herriot
Lyon, France, 69437